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Abstract
The protease-resistant prion protein (PrP
res) of a few natural scrapie isolates identified in sheep, reminiscent of the
experimental isolate CH1641 derived from a British natural scrapie case, showed partial molecular similarities to ovine
bovine spongiform encephalopathy (BSE). Recent discovery of an atypical form of BSE in cattle, L-type BSE or BASE, suggests
that also this form of BSE might have been transmitted to sheep. We studied by Western blot the molecular features of
PrP
res in four ‘‘CH1641-like’’ natural scrapie isolates after transmission in an ovine transgenic model (TgOvPrP4), to see if
‘‘CH1641-like’’ isolates might be linked to L-type BSE. We found less diglycosylated PrP
res than in classical BSE, but similar
glycoform proportions and apparent molecular masses of the usual PrP
res form (PrP
res #1) to L-type BSE. However, the
‘‘CH1641-like’’ isolates differed from both L-type and classical BSE by an abundant, C-terminally cleaved PrP
res product
(PrP
res #2) specifically recognised by a C-terminal antibody (SAF84). Differential immunoprecipitation of PrP
res #1 and PrP
res
#2 resulted in enrichment in PrP
res #2, and demonstrated the presence of mono- and diglycosylated PrP
res products. PrP
res
#2 could not be obtained from several experimental scrapie sources (SSBP1, 79A, Chandler, C506M3) in TgOvPrP4 mice, but
was identified in the 87V scrapie strain and, in lower and variable proportions, in 5 of 5 natural scrapie isolates with different
molecular features to CH1641. PrP
res #2 identification provides an additional method for the molecular discrimination of
prion strains, and demonstrates differences between ‘‘CH1641-like’’ ovine scrapie and bovine L-type BSE transmitted in an
ovine transgenic mouse model.
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Introduction
Prion diseases such as Creutzfeldt-Jakob disease (CJD) in
humans, scrapie in sheep and goats and bovine spongiform
encephalopathy (BSE) in cattle are tightly associated with the
accumulation of an abnormal form of a host-encoded cellular prion
protein (PrP C) in infected tissues [1]. The biochemical properties
of this disease-associated form of the protein (PrPd), which include
insolubility in non-denaturing detergents and partial resistance to
degradation by proteases, differ from those of the normal form.
Whereas the normal protein is fully sensitive to proteases, the
abnormal prion protein is only partly degraded (PrP
res) due to
removal of the amino-terminal end. In most cases, a large protease-
resistant C-terminal core fragment is identified which has a gel
mobility of ,19–21 kDa in its unglycosylated form. However, in
some prion diseases, such as some cases of human Creutzfeldt-
Jakob disease [2] or the H-type atypical form of BSE [3], a much
smaller C-terminal PrP
res product has also been reported.
A typical molecular signature of the BSE agent has been
identified by PrP
res Western blot analysis, which allows such
methods to be used to identify the possible presence of BSE in
sheep or goats [4–10]. The origin of the BSE agent in cattle is still
unknown, and its possible reservoir has not yet been identified. A
few isolates of TSEs were described in sheep that showed partial
similarities with experimental ovine BSE, with a lower molecular
mass of unglycosylated PrP
res than in most scrapie cases, as found
in ovine BSE. However the very high proportions of diglycosylated
PrP
res found in ovine BSE were not generally apparent in such
isolates. This was first demonstrated in the CH1641 experimental
scrapie isolate [11,12], then in a few natural scrapie cases in Great
Britain and France [13,14]. Bioassays performed in wild-type mice
to identify prion strains from TSE isolates were reported to
identify the biological signature of the BSE agent [15–18], but the
CH1641 source failed to transmit the disease to such mice [11,12].
Both CH1641 and ‘‘CH1641-like’’ natural isolates were however
transmitted in an ovine transgenic mouse model (TgOvPrP4),
showing similar PrP
res molecular features in both transgenic mice
and sheep, i.e. a low apparent molecular of unglycosyslated PrP
res
(referred as l-type PrP
res) [19,20]. In some of the cases this could be
not the unique molecular phenotype identified in all scrapie-
infected mice, with some of the mice also showing PrP
res with a
higher apparent molecular mass (h-type PrP
res) [20].
Deviant phenotypes of BSE have recently been reported in
cattle however (H and L-types, based on the PrP
res features in
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showed that these were consistent with the presence of two distinct
strains, both differing from the single classical BSE strain involved
in the food-borne BSE epidemic [23,25–27]. Thus, the possible
transmission of such forms of BSE in other species such as small
ruminants also needs to be considered. Recently the hypothesis has
been raised that the classical BSE epidemic might have originated
from the recycling of one of these atypical forms of BSE (L-type
BSE) after a first cross-species transmission, possibly in sheep
[27,28]. Recent studies of a transmissible mink encephalopathy
(TME) isolate in TgOvPrP4 mice also showed similar phenotypic
features to those of L-type BSE, suggesting a possible cross-species
transmission of L-type BSE by oral route [29]. Given their unusual
molecular properties, ‘‘CH1641-like’’ or CH1641 isolates might be
the result of a transmission of L-type BSE to sheep or might
represent similar isolates occurring in sheep.
In this study we compared the PrP
res molecular features of a
series of natural ‘‘CH1641-like’’ and experimental CH1641
scrapie isolates, with those of classical and L-type BSE, after
transmission to TgOvPrP4 ovine transgenic mice. We demon-
strated the abundance of a C-terminal PrP
res fragment (PrP
res #2),
which distinguished these ovine scrapie isolates from both bovine
classical and L-type BSEs after transmission in a common ovine
trangenic mouse model.
Results
‘‘CH1641-like’’ isolates and L-type BSE share similar
Western blot features to the usual PrP
res form (PrP
res #1)
in TgOvPrP4 mice
We compared the PrP
res Western blot profiles, after transmis-
sion in TgOvPrP4 ovine transgenic mice, of two recently identified
natural sheep TSE isolates (05-825 and 06-017) that showed PrP
res
molecular features comparable to the experimental CH1641
scrapie isolate, i.e., a low apparent molecular mass (l-type) close to
that found in ovine BSE. When the Bar233 antibody was used to
detect the usual form of PrP
res (PrP
res #1), the molecular features,
i.e. the apparent molecular masses of the three PrP
res glycoforms
and the glycoforms proportions, were similar in all PrP
res positive
mice in both experimental groups (Figure 1A). The glycoform
proportions in each of the natural 4 ‘‘CH1641-like’’ isolates (or in
CH1641) were significantly different from those of classical BSE
(p,0.0001 for all 15 tests), with essentially lower levels of
diglycosylated PrP
res than in classical BSE (Figures 1A and 2A).
Lane by lane comparisons revealed a slightly lower apparent
molecular massofunglycosylatedPrP
res inmiceinfected with scrapie
rather than ovine BSE, and also after PNGase deglycosylation
(Figure 1B). Nevertheless, these differences (0–0.3 kDa) remained
within the range of the possible variations of an individual sample in
a given Western blot experiment. These molecular features were
similar to those found in TgOvPrP4 mice infected with two other
previously described ‘‘CH1641-like’’ natural scrapie isolates, at first
or second passages (Figure 1C and 1D), in all (TR316211 isolate) or
in some (O104 isolate) of the mice [20].
In contrast, the PrP
res #1 molecular features in TgOvPrP4 mice
infected with ‘‘CH1641-like’’ isolates did not differ from those
found in mice infected with L-type BSE. The low apparent
Author Summary
The origin of the transmissible agent involved in the food-
borne epidemic of bovine spongiform encephalopathy
(BSE) remains a mystery. It has recently been proposed
that this could have been the result of the recycling of an
atypical, more probably sporadic, form of BSE (called
bovine amyloidotic spongiform encephalopathy, or L-type
BSE) in an intermediate host, such as sheep. In this study
we analyzed the molecular features of the disease-
associated protease-resistant prion protein (PrP
res) found
in the brain of transgenic mice overexpressing the ovine
prion protein after experimental infection with prions from
bovine classical and L-type BSEs or from ovine scrapie.
Scrapie cases included rare ‘‘CH1641-like’’ isolates, which
share some PrP
res molecular features with classical BSE and
L-type BSE. Scrapie isolates induced in transgenic mouse
brains the production of a C-terminally cleaved form of
PrP
res, which was particularly abundant from ‘‘CH1641-like’’
cases. In contrast, this C-terminal prion protein product
was undetectable in ovine transgenic mice infected with
bovine prions from both classical and L-type BSE. These
findings add a novel approach for the discrimination of
prions that may help to understand their possible changes
during cross-species transmissions.
Figure 1. Western blot analysis of PrP
res from ‘‘CH1641-like’’ isolates in TgOvPrP4 mice detected by Bar233 monoclonal antibody.
CH1641 and natural ‘‘CH1641-like’’ (06-017, 05-825, TR316211, and O104) scrapie isolates are compared with experimental ovine BSE (Ov BSE), L-type
(L-BSE), or classical (C-BSE) BSE in cattle. (A) and (B) show results in TgOvPrP4 mice at first passage and (C) and (D) at second passage. PrP
res was
analysed before ([A] and [C]) or after ([B] and [D]) PNGase deglycosylation.
doi:10.1371/journal.ppat.1000137.g001
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res was similar to that found
in mice infected with classical BSE (Figure 1C), and also after
PNGase deglycosylation (Figure 1D). Glycoform proportions did
not differ significantly between any of the natural ‘‘CH1641-like’’
isolates (or CH1641) and L-type BSE with all cases showing lower
levels of diglycosylated PrP
res than in classical BSE (Figures 1C
and 2B) (p.0.30 for all tests except the one comparing the
monoglycosylated PrP
res band in TR316211-infected mice for
which p=0.07).
Low apparent molecular masses of PrP
res were consistently
associated with strongly reduced labeling by P4 monoclonal
antibody (data not shown).
A C-terminal PrP
res fragment (PrP
res #2) is detected in
ovine transgenic mice infected with scrapie isolates but
not with L-type or classical BSE
We then used SAF84 for PrP
res detection, that identified an
additional band at ,14 kDa (PrP
res #2) in TgOvPrP4 mice
infected with the four natural ‘‘CH1641-like’’ isolates and with the
experimental CH1641 isolate (Figure 3A and 3C). This was
associated with lighter, more diffuse labeling below the well
defined ,19 kDa unglycosylated PrP
res #1 band, consistent with
the presence of a monoglycosylated form derived from the
,14 kDa PrP
res product. This PrP
res #2 fragment was not
detected in mice infected with classical BSE transmitted to sheep
or with L-type BSE in cattle (Figure 3A and 3C). The existence of
two distinct PrP
res fragments of ,19 and ,14 kDa detected with
SAF84 antibody only in the ‘‘CH1641-like’’ isolates was also
demonstrated after deglycosylation by PNGase treatment
(Figure 3B and 3D). Comparison of PrP
res profiles between
TgOvPrP4 mice and sheep or cattle (Figure S1) indicate that
TgOvPrP4 faithfully reproduced PrP
res features of ruminants
following transmission of scrapie or BSE, including regarding the
presence of PrP
res #2 in ‘‘CH1641-like’’ scrapie but not in BSE.
The ,14 kDa band was not detected in TgOvPrP4 mice that
had been infected with an isolate from cattle experimentally
infected with transmissible mink encephalopathy (TME) (Figure 3),
previously demonstrated to have phenotypic features similar to L-
type BSE in TgOvPrP4 mice (PrP
res of low apparent molecular
mass) [29].
We analyzed PrP
res in TgOvPrP4 mice infected from six
different BSE sources including (i) 3 natural isolates from cattle,
Figure 2. Glycoform ratios of PrP
res from ‘‘CH1641-like’’ isolates
in TgOvPrP4 mice. Glycoform ratios of PrP
res in individual mice
inoculated with ovine or bovine isolates (first passage) are shown in (A)
and (B), respectively. In (A), CH1641 is shown in red, and natural isolates
06-017 and 05-0825 in blue. In (B), Classical and L-type BSE are shown in
red and green, respectively. PrP
res was detected by Bar233 antibody.
doi:10.1371/journal.ppat.1000137.g002
Figure 3. Western blot analysis of PrP
res from ‘‘CH1641-like’’ isolates in TgOvPrP4 mice detected by SAF84 monoclonal antibody.
CH1641 and natural ‘‘CH1641-like’’ (06-017, 05-825, TR316211, and O104) scrapie isolates are compared with ovine BSE (Ov BSE), L-type (L-BSE), or
classical (C-BSE) natural BSE in cattle and transmissible mink encephalopathy experimentally transmitted to cattle (TME bov) [29]. (A) and (B) show
results in TgOvPrP4 mice at first passage and (C) and (D) at second passage. PrP
res was analysed before ([A] and [C]) or after ([B] and [D]) PNGase
deglycosylation.
doi:10.1371/journal.ppat.1000137.g003
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and (ii) 3 experimental sources from sheep (homozygous either for
A136R154Q71or A136R154R171 prnpallele) orfromC57Bl/6wild-type
mice. All these BSE sources showed a similar PrP
res profile with low
apparentmolecularmass(,19 kDa),closetothatfoundinCH1641-
infectedmice,butwithhigherlevelsofdiglycosylatedPrP
res,afterthe
use ofboth Bar233 and SAF84 antibodies(Figures 4A,4B,and 6). In
contrast to the CH1641 source, none of them showed detectable
levels of the ,14 kDa PrP
res fragment with SAF84 antibody, even
after PNGase deglycosylation (Figure 4B and 4C).
However, a ,14 kDa band was also detected in mice infected
with 5 natural scrapie isolates (Figure 4E), otherwise characterized
by a higher apparent molecular mass of PrP
res #1 compared to
CH1641 (Figure 4D) or to ovine BSE, although this ,14 kDa
band was clearly less intense than from ‘‘CH1641-like’’ isolates.
The C-terminal PrP
res fragment (PrP
res #2) is
preferentially associated with PrP
res of low apparent
molecular mass
We then evaluated the presence of the C-terminally cleaved
PrP
res fragment detected by SAF84 antibody in the experimental
sources that had been adapted to TgOvPrP4 mice. (1) Among the
two experimental scrapie isolates, unlike CH1641, this PrP
res
fragment was not detected from the SSBP/1 isolate (Figure 5). (2)
From experimental strains derived from mouse-adapted scrapie or
BSE strains, it was only detected in the 87V strain of scrapie which
is also characterized by a low apparent molecular mass of the
unglycosylated PrP
res #1 form, similar to that found in BSE, but
not in the three other scrapie strains (C506M3, Chandler and 79A)
otherwise characterized by a high molecular mass of unglycosy-
lated PrP
res (Figure 5).
In mice infected with natural scrapie isolates and CH641, the
respective proportions of the ,14 and ,19 kDa bands, as observed
after PNGase deglycosylation, were quantified and the ratios of
PrP
res #2/PrP
res #1 determined (Figure 6). The mean proportions
of PrP
res #2 in the ‘‘CH1641-like’’ isolates (3–5 mice analysed per
experimental group) represented 22.7% to 39.3% of the total signal,
except for the O104 isolate for which these proportions were smaller
(12.4%–20%) in 4 of the 5 mice analysed. The proportions of PrP
res
#2 in mice infected with the other scrapie isolates (‘‘non CH1641-
like’’) (1–3 mice analysed per experimental group), were below 10%
in most mice, except those infected with O111 (15.9%–19.4%).
Statistical analyses of the data confirmed the significantly higher
proportions of PrP
res #2 in mice infected with ‘‘CH1641-like’’
isolates (or CH1641) compared with other scrapie isolates
(p,0.0001), as well as the significantly higher proportions of PrP
res
#2 in the O111 isolate within the ‘‘non CH1641-like’’ isolates
(p=0.02).NosignificantdifferencesintheseproportionsofPrP
res#2
were found between the natural ‘‘CH1641-like’’ isolates and the
experimental CH1641 isolate (p=0.42).
Figure 4. Western blot analysis of PrP
res from BSE sources and from ‘‘non-CH1641-like’’ isolates in TgOvPrP4 mice. BSE sources
shown in (A–C) include BSE from cattle (lane 2), sheep homozygous for the A136R154Q171 (lane 3) or A136R154R171 (lane 4) prnp allele, goat (lane 5), and
cheetah (lane 6). ‘‘Non-CH1641-like’’ natural scrapie isolates include O171, O59, O69, O87, and O111 scrapie isolates. PrP
res in TgOvPrP4 mice (first
passage) was analysed before ([A,B,D,E]) or after ([C] and [F]) PNGase deglycosylation. PrP
res was detected by Bar233 antibody in (A) and (D) and by
SAF 84 antibody in (B), (C), (E), and (F).
doi:10.1371/journal.ppat.1000137.g004
"CH1641-Like" Sheep Scrapie and L-Type BSE
PLoS Pathogens | www.plospathogens.org 4 August 2008 | Volume 4 | Issue 8 | e1000137Transmission studies of the O104 isolate showed the presence of a
mixture of twodistinctPrP
res phenotypes,witheitherhigh (h-type) or
low (l-type) apparent molecular masses of unglycosylated PrP
res,i n
variable proportions in each individual mouse, as shown using
Bar233 detection after PNGase treatment (Figure 7A) [20]. The l-
type PrP
res, compared to the h-type, is only faintly labeled by the P4
antibody, but a P4-labelled PrP
res sub-population that migrates
similarly to the h-type PrP
res can be identified in mice with l-type
PrP
res (Figure 7B). When the SAF84 antibody was used (Figure 7C),
the C-terminal PrP
res fragment was detected in all the O104 infected
mice, but the lowest proportion (12.4%) (Figure 6) was found in the
sole mouse that showed the most important proportions of h-type
PrP
res (lanes 4 in Figure 7). These data are also consistent with a
preferential association of PrP
res #2w i t hP r P
res #1 of low apparent
molecular mass (l-type) in this scrapie isolate.
Differential immunoprecipitation shows PrP
res #2a sa
glycosylated PrP
res fragment
Immunoprecipitation experiments were carried out to enrich
the PrP
res #2 form in the samples and characterize it. Successive
rounds of immunoprecipitation on magnetic beads coated with
Sha31 N-terminal antibody that only recognizes PrP
res #1,
allowed progressive depletion of the PrP
res #1 in the samples
(Figure 8). After 7 rounds of immunoprecipitation, PrP
res #1
becomes only barely detectable. Immunoprecipitation was then
performed using the C-terminal SAF84 antibody that recognizes
both PrP
res #1 and PrP
res #2. Three bands were detected at ,22,
18, and 14 kDa, showing that PrP
res #2, previously identified as
an unglycosylated ,14 kDa band, is also isolated from the mouse
brains in monoglycosylated and diglycosylated forms.
The presence of this three band PrP
res #2 form was confirmed
by differential immunoprecipitation in CH1641, ‘‘CH1641-like’’
isolates, and 87V but also in the O111 ‘‘non-CH1641-like’’ scrapie
isolate. It could not be detected in mice infected with ovine BSE,
L-type BSE or cattle experimentally infected with transmissible
mink encephalopathy.
Neuropathological investigations of ‘‘CH1641-like’’
isolates in TgOvPrP4 mice
The neuropathological analyses of the first passage experiments
indicatedcomparabledistribution of disease-associated prionprotein
in the brain of the transgenic mice among the ‘‘CH1641-like’’ sheep
scrapie group (Figure S2). This was particularly clear for the 05-825
and 06-017 isolates that resulted in similar intensity of pathological
PrP accumulation (Figure S2C and S2D). Overall, these data were
also not dissimilar from those already described for the first passage
of L-type BSE[29].In both ‘‘CH1641-like’’ scrapie and L-type BSE,
the florid plaque type of PrPsc deposition reported in this transgenic
mouse line infected with classical BSE was never observed. However
it is possible to underline some clear distinctive features such as a
differenceinthecortextargetingthatwaslessintensecomparedtoL-
type BSE, even in the most severely affected cases (05-825 and 06-
017 isolates) (Figure S2E). Remarkably the types of PrP
d deposition
were also different; in the ‘‘CH1641-like’’ sheep scrapie group the
deposition of pathological PrP was fine granular compared to L-type
BSE in which plaque-like deposition were sometimes noticeable.
Also, in the mesencephalon (raphe dorsalis), the deposition was
intraneuronal for the ‘‘CH1641-like’’ sheep scrapie group but not in
the brain of mice infected with L-type BSE. These data thus indicate
some differences in the biological features of ‘‘CH1641-like’’ isolates,
not only with classical BSE, but also with L-type BSE.
Discussion
This study describes the molecular analyses of PrP
res after
transmission into TgOvPrP4 ovine transgenic mice from 4 natural
ovine scrapie isolates whose PrP
res features in sheep were similar to
those previously described for the experimental CH1641 scrapie
isolate [12]. Two of these previously unreported isolates (05-825
and 06-017) behaved as previously described for CH1641 and
another natural isolate (TR316211) during the first passage in
TgOvPrP4 mice, showing low molecular mass PrP
res (l-type PrP
res)
in all mice [19,20]. In contrast, all the TgOvPrP4 mice receiving 5
natural scrapie isolates characterized by high PrP
res molecular
masses (h-type PrP
res) in the sheep brain, showed PrP
res of high
molecular mass. Detailed analyses showed, as previously described
in the CH1641 isolate in sheep [9] and in TgOvPrP4 mice [19], a
slightly lower PrP
res molecular mass in TgOvPrP4 mice from the
‘‘CH1641-like’’ isolates than from ovine BSE, although the
resolution of small gels made discrimination difficult. Our results
are quite consistent with previous studies of the CH1641 isolate by
the immunohistochemical ‘‘peptide mapping’’ method, which
revealed that PrP
d in the CH1641 isolate was truncated further
upstream in the N terminus than from experimental BSE [30].
The biochemical PrP
res features of these scrapie isolates differ from
Figure 5. Western blot analysis of PrP
res from experimental
scrapie and BSE sources in TgOvPrP4 mice. Scrapie sources
include SSBP1 and CH1641 experimental scrapie isolates and Chandler,
87V, 79A, and C506M3 scrapie strains in TgOvPrP4 mice (second
passage). BSE is derived from C57Bl/6 mice infected with classical BSE
(Mu BSE) (second passage in TgOvPrP4 mice). PrP
res was analysed
before (A, B) or after (C) PNGase deglycosylation and detected using
Bar233 (A) or SAF84 (B, C).
doi:10.1371/journal.ppat.1000137.g005
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glycosylated PrP
res (50%–60%), whereas ovine BSE is character-
ized by higher proportions of di-glycosylated PrP
res [4,9,12].
Molecular discrimination of strains based on the relative
proportions of glycoforms is however less reliable than that of
PrP
res molecular masses, given the large measurement variations
and poor standardization of analytical methods [9,10,31–33].
Furthermore glycoforms proportions of BSE in sheep have only
been determined from a very limited number of sources. A recent
study of classical BSE in cattle showed large individual variations
(,20%) in the proportions of di-glycosylated PrP
res [34].
The question of a possible transmission of BSE in small
ruminants now needs to be re-examined considering the recent
identification of atypical cases of BSE (H-type or L-type) in cattle
[21–24]. Recent studies have indeed hypothesized that cross-
species transmission of such rare atypical cases could be at the
origin of the BSE epidemic in cattle [27,28,35]. The first
experimental support for this hypothesis was obtained following
the discovery of a BSE-like phenotype in mice following
transmission of L-type BSE in wild-type mice (C57Bl, SJL) [27]
or in an ovine transgenic (tg338) mouse line [28]. However, unlike
tg338, which expressed 8- to 10-fold levels of V136 R154 Q171 ovine
PrP, the phenotype of the L-type BSE remained distinct from
classical BSE during at least two passages in TgOvPrP4 mice that
expressed 2- to 4-fold levels of the A136 R154 Q171 ovine PrP [29].
It is noteworthy that, in cattle, the essential difference between L-
type BSE and classical BSE is the slightly lower apparent
molecular mass and the lower proportions of diglycosylated PrP
res
[22–24], reminiscent of the differences between CH1641 and
classical BSE experimentally transmitted to sheep [9,12,30]. The
phenotypic features of L-type BSE have not yet been reported in
sheep. In this study we showed that the PrP
res molecular masses
and glycoform proportions between ‘‘CH1641-like’’ scrapie
isolates and L-type BSE transmitted into TgOvPrP4 mice were
indistinguishable, in addition to survival periods in the same range
at second passage.
However our study revealed that a highly sensitive C-terminal
antibody (SAF84) recognised an abundant PrP
res product (PrP
res
#2) in TgOvPrP4 mice infected with ‘‘CH1641-like’’ isolates, the
unglycosylated form of which migrates at ,14 kDa, in addition to
the usual PrP
res product (PrP
res #1) which migrates at ,19 kDa in
its unglycosylated form. The presence of mono- and di-
glycosylated forms derived from this PrP
res cleavage product was
confirmed by differential immunoprecipitation of PrP
res #1 and
PrP
res #2. Depletion of PrP
res #1 using N-terminal antibodies
allowed the samples to be enriched in C-terminally cleaved PrP
res
#2, which then appeared in a 3-band pattern between 14 and
22 kDa. Such experiments also confirm that PrP
res #2 is only
faintly recognized by Sha 31 antibody, which recognizes the 148–
155 region of the ovine PrP protein, suggesting that this region is
absent from most of the PrP
res #2 fragments. PNGase
deglycosylation also facilitated the identification of PrP
res #2,
and permitted quantification of the respective proportions of PrP
res
#2 and PrP
res #1. Whereas PrP
res #2 was abundant in
TgOvPrP4 mice infected with ‘‘CH1641-like’’ isolates, lower
levels of PrP
res #2 could also be detected from 5 natural isolates
with h-type PrP
res transmitted into TgOvPrP4 mice. C-terminally
cleaved PrP
res products have previously been described in sporadic
or genetic Creutzfeldt-Jakob disease in humans [2]. Although the
presence of low levels of PrP
res #2 in BSE and L-type BSE cannot
be fully excluded, this PrP
res form remained undetected in our
experiments with these BSE forms, even after differential
immunoprecipitation. This was also the case in classical BSE
transmitted in a variety of different species. Interestingly, similar
Figure 6. Proportions of PrP
res #2 from scrapie sources transmitted to TgOvPrP4 mice. Proportions of PrP
res #2 were evaluated by
repeated Western blot analyses of the samples after PNGase deglycosylation and detection using SAF84 antibody. In the case of O104-infected mice,
the mice are numbered as indicated in Figure 7 showing Western blot results.
doi:10.1371/journal.ppat.1000137.g006
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from cattle experimentally infected with transmissible mink
encephalopathy (TME), consistent with previous studies showing
similarities with L-type BSE [29]. Our results thus reinforce the
molecular discrimination of ‘‘CH1641-like’’ scrapie isolates from
classical BSE, but also indicate a clear molecular difference with L-
type BSE transmitted from cattle to ovine transgenic mice.
However, further comparisons including those of biological and
histopathological features during serial passages in this mouse
model will be required, as well as transmission studies performed
from L-type BSE experimentally transmitted to sheep.
We have also recently described the identification of a C-
terminally cleaved PrP
res #2 form in H-type BSE, in cattle and
after transmission to C57Bl/6 mice [3]. However, a relationship
between ‘‘CH1641-like’’ scrapie isolates and H-type BSE seems
unlikely. H-type BSE is indeed characterized by a high PrP
res
molecular mass comparable to most natural scrapie cases, in
contrast to the low PrP
res molecular mass, which is the hallmark of
‘‘CH1641-like’’ isolates. Although the transmission of H-type BSE
in sheep has not yet been reported, a high PrP
res molecular mass
was maintained upon transmission in tg338 ovine transgenic mice
[26]. Unfortunately, direct comparisons with H-type BSE in
TgOvPrP4 mice were not possible since we were unable to
transmit the disease from several cattle H-type isolates to these
mice, at least at first passage [29]. As these same H-type isolates
were transmitted in tg338 expressing higher levels of the V136 R154
Q171 ovine PrP protein [26], this could suggest a high species and/
or strain barrier for H-type BSE in sheep. Conversely, both
classical and L-type BSEs were readily transmitted in TgOvPrP4
mice [19,29].
The presence of PrP
res #2 within the different scrapie sources,
was preferentially associated with PrP
res #1 of low molecular
mass. When several experimental scrapie sources were analysed,
PrP
res #2 was only detected in the 87V strain, characterized by l-
type PrP
res, but not in C506M3, Chandler or 79A strains or in the
SSBP/1 isolate with h-type PrP
res, still emphasizing the need of
further comparisons between 87V and ‘‘CH1641-like’’ isolates
[20]. Although PrP
res #2 could also be detected after the
transmission of natural scrapie isolates with high molecular mass,
the levels were consistently lower than in ‘‘CH1641-like’’ isolates.
It might be that the presence of low levels of PrP
res #2 in scrapie
isolates with h-type PrP
res indicates a mixture of PrP
res phenotypes
in these scrapie sources, with the levels of l-type PrP
res
undetectable. This possibility should be considered in the light of
certain observations. (1) A scrapie case with both h-type and l-type
PrP
res has recently been described in the UK, each PrP
res
phenotype originating from two different brain areas [14]. (2)
Our recent transmission studies of two ‘‘CH1641-like’’ isolates
(O100 and O104) from the same flock into TgOvPrP4 showed the
presence of h-type PrP
res in some of the mice suggesting a possible
mixture of the two PrP
res phenotypes in the initial ovine scrapie
isolates; these two PrP
res phenotypes might be selected, at least in
part, during the second passage in TgOvPrP4 mice [20]. Studies of
the initial ovine brain samples by immunohistochemistry indeed
revealed the presence of differently cleaved PrP
res forms in
different brain nuclei [13]. (3) Transmission of scrapie in cattle
from a brain pool (British source) with h-type PrP
res produced two
cows with l-typePrP
res [36]. h-type PrP
res was detected in a second
brain sample from one of the two animals. (4) Similar results were
observed in a bovine transgenic mouse line, the mobility in mice
being faster than in the original scrapie isolate (Irish source) [37].
All together, these data suggest that l-type PrP
res could be present
in a number of scrapie sources. The identification of ‘‘CH1641-
Figure 7. Western blot analysis of PrP
res from O104 natural
scrapie isolate in TgOvPrP4 mice. PrP
res was analysed in TgOvPrP4
mice (first passage) by Western blot after PNGase deglycosylation and
detected using Bar233, P4, and SAF84 monoclonal antibodies in (A), (B),
and (C), respectively. PrP
res from individual mice infected with O104
isolate (first passage) is shown, with BSE derived from BSE-infected
C57Bl/6 mice (Mu BSE) and C506M3 scrapie controls in TgOvPrP4 mice
(second passage). O104-infected mice are numbered as indicated in
Figure 5 showing the proportions of PrP
res #2.
doi:10.1371/journal.ppat.1000137.g007
Figure 8. Enrichment of PrP
res #2 by differential immunopre-
cipitation. Western blot analysis of PrP
res from TgOvPrP4 infected with
a ‘‘CH1641-like’’ isolate (TR316211). PrP
res released from beads after
each capture cycle is shown for 5 successive cycles using Sha31-coated
beads (lanes 3 to 7, respectively), then from the following capture cycle
using SAF84-coated beads (lane 8). PrP
res controls from C506M3 strain
and TR316211 are shown on lanes 1 and 2, respectively. PrP
res was
detected using SAF84 antibody that recognizes both PrP
res #1 and
PrP
res #2 forms.
doi:10.1371/journal.ppat.1000137.g008
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samples in which the l-type PrP
res of low molecular mass is more
abundant.
Further characterization of the biological properties of scrapie
sources with l-type PrP
res will be required firstly to establish
whether these correspond to a single strain of infectious agent or
involve a variety of distinct scrapie strains, and secondly to better
understand the characteristics of their transmission.
Materials and Methods
TSE sources
The TSE sheep isolates (Table 1) included the experimental
CH1641 scrapie isolate (kindly provided by N. Hunter, Institute
for Animal Health, Edinburgh) and four natural French
‘‘CH1641-like’’ TSE isolates. Transmission studies and initial
data concerning the molecular analyses of CH1641 and of two
natural ‘‘CH1641-like’’ isolates (O104, TR316211) transmitted to
TgOvPrP4 ovine transgenic mice, have already been described
[19,20]. Two other field isolates from A136 R154 Q171 homozygous
sheep (05-825 and 06-017) were now included, that showed a low
apparent molecular mass of unglycosylated PrP
res (0.1–0.4 kDa
lower than in cattle BSE), as also described in experimental ovine
BSE and reduced PrP
res labelling with P4 monoclonal antibody in
comparison to most natural scrapie cases that show PrP
res of
higher molecular mass.
Other TSE sources examined in TgOvPrP4 mice included (i) 5
natural scrapie isolates identified by clinical surveillance in France,
with PrP
res of high apparent molecular mass (‘‘non-CH1641-like’’)
(Table 1); (ii) the SSBP/1 experimental scrapie isolate [19]; (iii)
experimental scrapie strains, derived from mouse-adapted strains,
C506M3, Chandler, 79A, 87V [19,20]; (iv) BSE from cattle or
obtained after natural transmission (goat, cheetah) [6,18,38] or
experimental transmission (sheep homozygous for the A136R154Q171
or A136R154R171 prnp allele, wild-type mouse)[19,39–41]; and (v) an
experimental bovine isolate of transmissible mink encephalopathy
[29].
Breeds and prnp genotypes of sheep and the survival periods
observed after transmission in TgOvPrP4 ovine transgenic mice
are shown in Table 1.
Transmission studies
Four- to six-week-old female TgOvPrP4 ovine transgenic mice
[42] were inoculated intra-cerebrally with 10% (first passage) or
1% (second passage) (wt/vol) brain homogenates in 5% glucose in
distilled water (20 ml per animal). The brains were sampled at the
terminal stage of the disease or death of the animal due to
intercurrent disease or ageing. The guidelines of the French
Ethical Committee (decree 87–848) and European Community
Directive 86/609/EEC regarding mice were respected. Experi-
ments were performed in the Biohazard prevention area (A3) of
the author’s institution with the approval of the Rho ˆne-Alpes
Ethical Committee for Animal Experiments. The whole brain of
every second mouse was frozen and stored at 280uC before
Western Blot analysis. The other brains were fixed in 10% formol-
saline solution for histopathological examinations.
Histological examinations
Post-fixed brain were routinely embedded in paraffin after a 1
hour formic acid (98%–100%) treatment. De-waxed and re-
hydrated 5 mm brain sections were then either stained using
hematoxylin-eosin in order to study vacuolar lesions or immuno-
stained for PrP
sc using SAF84 (SPI Bio) and 2G11 (Pourquier)
monoclonal antibodies with or without an additional step using
streptomycin sulfate, following a procedure reported in detail
elsewhere [43]. A peroxydase-labeled avidin-biotin complex
(Vectastain Elite ABC, Vector Laboratories) was used to amplify
the signal. Final detection was achieved using a solution of
diaminobenzidine intensified with nickel chloride (Zymed),
producing black deposits. Finally, slides counterstained with
aequous hematoxylin were observed under a microscope coupled
to an image analysis workstation (Morpho Expert software,
ExploraNova). The lesion profiles were built following referential
criteria [44] using a computer-assisted method [45].
Extraction of PrP
res
PrP
res was obtained following concentration by ultra-centrifuga-
tion from half of the mouse brains homogenised in glucose 5% in
distilledwater(20%wt/vol).A600 mlvolumewasmadeup to1.2 ml
in glucose 5%, before incubation with proteinase K (10 mg/100 mg
brain tissue)(Roche) for 1 h at37uC.N-lauroylsarcosyl 30% (600ml;
Sigma) was added. After incubation at room temperature for
15 min, samples were then centrifuged at 100,000 rpm for 2 h on a
400 ml 10% sucrose cushion, in a Beckman TL100 ultracentrifuge.
Pellets were resuspended and heated for 5 min at 100uCi n5 0ml
TD4215 denaturing buffer (SDS 4%, b-mercaptoethanol 2%,
glycine 192 mM, Tris 25 mM, sucrose 5%). In some experiments,
deglycosylation was performed using PNGase F (kit P07043,
BioLabs), as previously described [20].
Differential immunoprecipitation
Differential immunoprecipitation was used to enrich the
samples in the C-terminally cleaved form of PrP
res (PrP
res #2),
by depletion of the usual form of PrP
res (PrP
res #1).
Superparamagnetic polystyrene beads coated with a monoclo-
nal antibody specific for Fc on all mouse IgG (DynabeadsH Pan
Mouse IgG_DYNAL #110.41) were used as recommended by the
manufacturer. After each step, the beads were recovered using
Dynal PMC. 50 ml bead aliquots were washed 3 times in 5 volumes
of coating buffer (PBS with 0.1% of BSA). Beads (50 ml of beads
Table 1. Breeds and prnp genotypes of ovine scrapie sources
and survival periods after transmission in TgOvPrP4 ovine
transgenic mice.
Breed
PrP
Genotype*
Survival Periods,
mean6SD (d.p.i.)**
CH1641 Cheviot AxQ/AxQ 245617 (12)
‘‘CH1641-like’’ natural isolates
O104 Manech te ˆte rousse VRQ/VRQ 248650 (10)
TR316211 Unknown ARQ/ARQ 235626 (8)
05-825 Unknown ARQ/ARQ 223625 (6)
06-017 Unknown ARQ/ARQ 239630 (10)
Other natural scrapie isolates
O56 Manech te ˆte rousse ARH/ARH 3926160 (9)
O69 Manech te ˆte rousse ARQ/ARQ 252616 (14)
O87 Manech te ˆte rousse VRQ/ARQ 3536144 (6)
O111 Unknown ARQ/ARQ 296620 (11)
O171 Pre ´alpes du Sud ARQ/ARQ 247614 (9)
*Amino acids 136, 154, and 171.
**Number of animals.
doi:10.1371/journal.ppat.1000137.t001
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were then coated with IgG mouse monoclonal antibodies Sha 31
or SAF84 (ascitic fluids; SPI-Bio, France) for PrP
res #1 or PrPres
#2 capture, respectively. Sha31 and SAF84 recognise the ovine
PrP sequences 148-YEDRYYRE-155 and 167-RPVDQY-172,
respectively. For each cycle of PrP
res capture, the sample was
incubated with antibody-coated beads for 1 h at room tempera-
ture under continuous rotation at 60 rpm.
After PrP
res ultracentrifugation, the pellets obtained from 2 mg
brain tissues were resuspended in 20 ml immunoprecipitation buffer
(phosphate-buffered saline [PBS] at pH 7.4 and 0.3% of N-lauroyl
sarcosyl) and heated 5 min at 100uC, before addition of a 30 ml
suspension of antibody-coated beads. After completing the beads
suspension to 1 ml, the sample was enriched in PrP
res #2, by
depleting the PrP
res #1i n5t o7s u c c e s s i v er o u n d so fP r P
res #1
capture using Sha31-coated beads. The supernatants collected after
each capture cycle were used for the next one. PrP
res #2 was then
captured by SAF84-coated beads. At the end of each capture cycle,
PrP
res was removed from the beads by heat denaturation for 5 min
at 100uCi n3 0ml TD4215 buffer prior to Western blot analyses.
Western blot analyses
Western blot analysis was performed as previously described
[20] by 15% SDS-PAGE and electroblotting on nitrocellulose
membranes. PrP
res was detected with P4 (0.2 mg/ml) (93-
WGQGGSH-99 ovine PrPsequence; R-Biopharm, Germany),
Bar233 (1/5000) (144-FGNDYEDRYYRE-155 ovine PrP se-
quence; kindly provided by J. Grassi, C.E.A.-Saclay, France),
Sha31 (1/10 from TeSeE Bio-Rad sheep and goats kit; Bio-Rad,
France) or SAF84 (SPI-Bio, France) mouse monoclonal antibodies.
Peroxidase-labelled conjugate anti-mouse IgG (H+L) (1/2500 in
PBST; ref 1010-05; Clinisciences, France) was used to detect P4,
Bar233, and Sha31 antibodies, whereas SAF84 was used as
horseradish peroxidase antibody. Streptavidin (5 ng/ml) (S5512)
was added to the conjugate solution. Bound antibodies were then
detected by direct capture with the Versa Doc (Bio-Rad) analysis
system using the ECL chemiluminescent substrate (Amersham,
France). Quantitative studies were performed using Quantity One
(Bio-Rad) software, and the apparent molecular masses were
evaluated by comparing the positions of the PrP
res bands with a
biotinylated marker (B2787) (Sigma, France).
Statistical analyses
The glycoforms proportions of the four ‘‘CH1641-like’’ isolates
and the CH1641 isolate were compared with each other and the
glycoforms proportions of both classical BSE and L-type BSE were
compared with those of each natural ‘‘CH1641-like’’ isolate and
with the experimental CH1641 isolate. Comparison of classical
BSE alone with each ‘‘CH1641-like’’ isolate and with CH1641 at
first passage implies 5 tests for each of the 3 PrP
res #1 bands. In
view of the high total number of tests (19 for each PrP
res band),
paired-sample t tests with Bonferroni adjustment were used to
preclude the detection of spurious differences in glycoform
proportions.
A classical analysis of variance was used for comparisons of PrP
res
#2. The statistical analysis was performed with R software (R
version 2–6.0 [2007-11-03]: A language and environment for
statistical computing. R Foundation for Statistical Computing,
Vienna, Austria. ISBN 3-900051-07-0; http://www.R-project.org).
Supporting Information
Figure S1 Western blot comparisons of PrP
res in the brains of
TgOvPrP4 mice and sheep or cattle. PrP
res from sheep (lanes 1, 5,
and 7) or cattle (lane 3) and from TgOvPrP4 mice (lanes 2, 4, 6,
and 8) was detected using Bar233 (A) and SAF84 (B) antibodies.
TSE sources were CH1641, BSE-L, 06-017 (‘‘CH1641-like’’), and
BSE-C.
Found at: doi:10.1371/journal.ppat.1000137.s001 (2341 KB TIF)
Figure S2 Neuropathological features of ‘‘CH1641-like’’ isolates
in TgOvPrP4 mice. (A-D) Brain lesion profiles (left panels) and
disease-associated prion protein brain mapping (right panels)
observed in the brains of TgOvPrP4 mice (n=3–7) infected at first
passage with O104, TR316211, 05-825, or 06-017 isolates. 1.
Dorsal medulla nuclei. 2. Cerebellar cortex. 3. Superior colliculus.
4. Hypothalamus. 5. Central thalamus. 6. Hippocampus. 7.
Lateral septal nuclei. 8. Cerebral cortex at the level of thalamus. 9.
Cerebral cortex at the level of septal nuclei. (E) Immunohisto-
chemical detection of disease-associated prion protein in the brain
of TgOvPrP4 mice; signal intensity was different in the cortex
between L-type BSE and ‘‘CH1641-like’’ sheep scrapie. In the
raphe dorsalis intensity was similar, but the deposition was slightly
different and appeared intraneuronal in the case of the ‘‘CH1641-
like’’ sheep scrapie group.
Found at: doi:10.1371/journal.ppat.1000137.s002 (0.88 MB TIF)
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